Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicentric, Post-market Clinical Investigation to Evaluate the Performance and Safety of Connettivina Bio Line in Management of Acute and Chronic Wounds

NCT06108999 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.

NCT NCT06108999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06108999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicentric, Post-market Clinical Investigation to Evaluate the Performance and Safety of Connettivina Bio Line in Management of Acute and Chronic Wounds
Lead sponsor
Fidia Farmaceutici s.p.a.
Phase
Not applicable
Overall status
Unknown status
Start date
July 29, 2022
Completion date
September 30, 2024
Enrollment
170 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

wound heal, wound; foot